Cancer research award to UConn resident
Dr. Joshua A. Fein, a third-year resident in the UConn internal medicine residency program and current applicant for hematology/oncology fellowship programs, has been selected by...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Dr. Joshua A. Fein, a third-year resident in the UConn internal medicine residency program and current applicant for hematology/oncology fellowship programs, has been selected by...
An Alexion drug could pay dividends for new Alexion parent AstraZeneca. The UK-based pharma giant, which acquired the drug, ALXN1840, as part of its $39 billion...
The Undergraduate Research Program at UConn offers students interested in health and biomedical sciences a unique first-hand experience to work at UConn Health. In a...
Cara Therapeutics and Vifor Pharma report that the FDA has approved KORSUVA™ (difelikefalin) for injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease...
The FDA has approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee),...
By John Burkhardt, Pfizer Groton Site Head As the world increases our understanding of the importance and benefits of diversity in thought, I am proud and...
Elm Street Ventures has been instrumental in bringing hundreds of jobs and hundreds of millions in investments to New Haven. “There are a lot of...
A team of UConn researchers –- including Assistant Professor of Chemistry in the College of Liberal Arts and Sciences Jessica Rouge and Associate Professor of...
Avera Health and Sema4 have launched a new precision medicine initiative. Avera Cancer Institute has had a robust precision oncology program for several years in...
Bioasis Technologies reports that the Japanese Patent Office has issued Japanese Patent No. 2019-189551 Notice of Allowance for the company’s xB3-IDS fusion proteins. “We are excited...